Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
Clinical trial NCT04375228 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04375228
- Sponsor
- Columbia University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2025-05-14
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.